Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 8Classical hematology 5Gastrointestinal 3Thoracic 2Plasma cell 1Myeloid 1Lymphoid 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1874Lung Neoplasms 1301Small Cell Lung Carcinoma 327Colorectal Neoplasms 268Breast Neoplasms 243Melanoma 221Neoplasms 218Ovarian Neoplasms 193Neoplasm Metastasis 181Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 151Stomach Neoplasms 143Head and Neck Neoplasms 120Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 110Esophageal Neoplasms 109Prostatic Neoplasms 106Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 89Mesothelioma 88Colonic Neoplasms 86Mesothelioma, Malignant 81Carcinoma, Hepatocellular 74Brain Neoplasms 69Sarcoma 64Disease 62Adenocarcinoma of Lung 59Carcinoma, Transitional Cell 54Liver Neoplasms 49

Interventions

trilaciclib 1pegylated granulocyte colony-stimulating factor 1PM 01183 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neutropenia × Thoracic × 1 year × Clear all
NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
30 enrolled
Thoracic

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma

NCT07205536 2025-12-11

ANC-IIT-004

Affiliated Hospital of Nantong University

Phase 2 Recruiting
30 enrolled
Classical hematologyThoracic

Neutropenia, Thoracic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡